Additionally, the treatment with another MRA—eplerenonon—in an animal model of hypertensive HF resulted in the inhibition of MMP-2, MMP-12 and MMP-13 activities, as well as improvement of myocardial remodeling [114]. The gene discussed is MMP2; the disease is hydrops fetalis.